Dr. Adela Osman was recently promoted to 69É«ÇéƬ's Head of Global Medical after previously serving as Chief Medical Officer for 69É«ÇéƬ South Africa. In this Inside 69É«ÇéƬ Q&A, Adela explains why she chose a career in the life and health insurance industry, what 69É«ÇéƬ Magic means, and how she plans to build on the successful legacy of 69É«ÇéƬ’s medical team.
I had a thriving medical practice and enjoyed that work, but life led me to consider the insurance space, where I was offered a position as a marketing medical director for a direct insurer. I absolutely loved the job. There is not much formal insurance medical training available in South Africa, so I learned a lot by attending insurance conferences. It was at one of these, an 69É«ÇéƬ client event, where I was recruited by 69É«ÇéƬ, and I have found my professional home with this remarkable company.
The 69É«ÇéƬ ethos is very client-focused, and we've become synonymous with high service levels, constant innovation, and superior client engagement, which is consistent with 69É«ÇéƬ worldwide. In South Africa, we call it "69É«ÇéƬ Magic." We have an extremely dynamic group of people who work fantastically together, consistently delivering value to clients and colleagues alike. We are regularly commended for the great vibe and energy we have when we're together, so we coined 69É«ÇéƬ Magic.
My role in South Africa went beyond serving as chief medical officer. I also headed up the research and development team and was part of the Executive Committee. This allowed me opportunities to be part of the development and execution of the business strategy.
Having the ability to apply the same set of skills to effect change across the global business is fantastic. But I am most excited to be working more closely with my incredibly experienced and talented team. Our vision is to maintain and grow our global leadership in insurance medicine and remain a key reason for clients to choose 69É«ÇéƬ as their primary reinsurer.
As has become a trademark of the 69É«ÇéƬ medical team under my predecessor, Dr. Dan Zimmerman, who is now 69É«ÇéƬ's Chief Science Advisor, I also look forward to seeing the global medical team build on its support of 69É«ÇéƬ initiatives in all areas of the business.
Across the life and health insurance industry globally, the financial impact of a slowing economy, COVID-19 pandemic, the climate crisis, wars, and other factors has put a lot of strain on consumers. And we know that insurance generally is a bit of a grudge purchase to begin with – people buy insurance because they feel they have to, not because they want to. While this might not be a new challenge for insurers, it is becoming more acute.
From the medical side, the ongoing pandemic and its many ripple effects – long Covid, mental health issues, delayed treatments, and so on – certainly remain a primary concern. I think we also need to take a close look at navigating regulations. As innovations such as genetic medicine bring new concerns around data protection and introduce issues such as the right to underwrite, insurers will need to pay close attention and transform in order to best serve consumers.
As stated earlier, we want to build on 69É«ÇéƬ's established reputation as a leader in insurance medicine. When people talk about insurance medicine, we want them to think about 69É«ÇéƬ and its medical team as the gold standard. My ultimate goal is for 69É«ÇéƬ to become synonymous with thought leadership and medical excellence while serving as a strong backbone and support engine for a thriving business that consistently delivers added value for our clients and the people they serve.
